SCOR (SCR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Feb, 2026Executive summary
Net income reached EUR 425 million for H1 2025, with EUR 226 million in Q2 2025, and annualized ROE of 20.3% for H1 and 22.6% for Q2, reflecting strong performance across all business segments.
Economic value increased by 10.5% at constant economics, reaching EUR 8.5 billion at Q2 2025, despite a reported decrease due to mark-to-market impacts and dividend payments.
Group solvency ratio stood at 210% as of June 30, 2025, at the upper end of the optimal range, supported by strong capital generation.
P&C combined ratio improved to 82.5% in Q2 2025, driven by low natural catastrophe losses and strong attritional performance.
Life & Health delivered results in line with expectations, with a robust new business CSM and ongoing execution of profitability plans.
Financial highlights
H1 2025 net income was EUR 425 million, with Q2 2025 net income at EUR 226 million; annualized ROE was 20.3% for H1 and 22.6% for Q2.
Insurance revenue for H1 2025 was EUR 7,883 million, down 3.8% year-over-year; Q2 2025 revenue was EUR 3,819 million, down 6.5%.
Investment income rose to EUR 480 million in H1 2025, with a return on invested assets of 3.7% and regular income yield of 3.5% in Q2.
Operating cash flow increased to EUR 546 million in H1 2025, with Q2 2025 at EUR 395 million.
Book value per share was EUR 23.09 and economic value per share was EUR 47.35 as of June 30, 2025.
Outlook and guidance
Forward 2026 targets reaffirmed: 9% annual economic value growth, solvency ratio between 185%-220%, and ROE above 12% p.a.
P&C insurance revenue growth guidance for 2025 revised to flattish, with optimism for 2026.
Continued focus on disciplined underwriting, profitable and diversifying lines, and value creation in both L&H and P&C.
Expects continued overcapacity in reinsurance, likely to pressure pricing, but remains focused on underwriting discipline and capital redeployment.
Confident in ability to execute the Forward 2026 strategic plan despite competitive pressures.
Latest events from SCOR
- FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 20254 Mar 2026 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 202410 Feb 2026 - January 2026 renewals drove 14.8% EGPI growth and improved underwriting in a competitive market.SCR
Investor update4 Feb 2026 - Strong P&C and investment results offset by L&H review, solvency robust at 203%.SCR
Q3 202414 Jan 2026 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust solvency.SCR
Investor Day 202411 Jan 2026 - 9.6% EGPI growth driven by Specialty and Alternative Solutions, with stable profitability.SCR
Investor Update9 Jan 2026 - Q4 2024 net income EUR 233m, adjusted FY net income EUR 728m, solvency at 210%, dividend EUR 1.8.SCR
Q4 202413 Dec 2025 - Q1 2025 net income hit EUR 200m, with robust solvency and strong segment performance.SCR
Q1 202518 Nov 2025 - Q3 2025 delivered EUR 217m net income, 21.5%–22.1% ROE, and a 210% solvency ratio.SCR
Q3 20252 Nov 2025